Mankind Pharma flags condom price hike as West Asia conflict lifts petroleum-linked input costs
India's condom market leader Manforce, with ~30% share, may raise prices on its Rs 100-150 per 10-pack range if oil stays above $100/barrel. Petroleum-derived inputs and latex sourcing through Malaysia's Karex are squeezing margins. Mankind also launched a generic semaglutide shot at Rs 1,300 to undercut tirzepatide priced up to Rs 27,000.
Mankind Pharma, India's condom market leader with ~30% share via Manforce, may hike prices if West Asia conflict keeps oil elevated, raising petroleum-linked input costs. Separately, it launched a generic semaglutide weight-loss shot targeting tier-2/3 cities.
Why this matters
Mankind is balancing margin pressure on Manforce condoms with aggressive pricing in diabetes care, launching a Rs 1,300 generic semaglutide to undercut tirzepatide at up to Rs 27,000.
Retail-brand signals steady at 471 over the last 90 days.